Population Health Sciences

You are here

Publications

Found 234 results

Author Title [ Type

] Year

Filters: First Letter Of Last Name is G [Clear All Filters]

Journal Article

Sanelli PC, Pandya A, Segal AZ, Gupta A, Hurtado-Rua S, Ivanidze J, Kesavabhotla K, Mir D, Mushlin AI, Hunink MGM. 2014. Cost-effectiveness of CT angiography and perfusion imaging for delayed cerebral ischemia and vasospasm in aneurysmal subarachnoid hemorrhage.. AJNR Am J Neuroradiol. 35(9):1714-20.

Gupta A, Mushlin AI, Kamel H, Navi BB, Pandya A. 2015. Cost-Effectiveness of Carotid Plaque MR Imaging as a Stroke Risk Stratification Tool in Asymptomatic Carotid Artery Stenosis.. Radiology. 277(3):763-72.

Behrends CN, Eggman AA, Gutkind S, Bresnahan MP, Fluegge K, Laraque F, Litwin AH, Meissner P, Shukla SJ, Perumalswami PV et al.. 2019. A Cost Reimbursement Model for Hepatitis C Treatment Care Coordination.. J Public Health Manag Pract. 25(3):253-261.

Schackman BR, Jeng PJ, Flash MJE, Mejia M, Oksuzyan S, Scott JA, Freedberg KA, Kulkarni SP, Garland WH. 2019. Cost of an HIV Medical Care Coordination Program in Los Angeles County.. J Acquir Immune Defic Syndr. 81(1):e15-e17.

Yu H, Chen Z, Ballman KV, Watson MA, Govindan R, Lanc I, Beer DG, Bueno R, Chirieac LR, Chui MHerman et al.. 2019. Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma.. J Thorac Oncol. 14(1):25-36.

Yu H, Chen Z, Ballman KV, Watson MA, Govindan R, Lanc I, Beer DG, Bueno R, Chirieac LR, Chui MHerman et al.. 2019. Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma.. J Thorac Oncol. 14(1):25-36.

Yu H, Chen Z, Ballman KV, Watson MA, Govindan R, Lanc I, Beer DG, Bueno R, Chirieac LR, Chui MHerman et al.. 2019. Correlation of PD-L1 Expression with Tumor Mutation Burden and Gene Signatures for Prognosis in Early-Stage Squamous Cell Lung Carcinoma.. J Thorac Oncol. 14(1):25-36.

Patel N, Golan R, Halpern JA, Sun T, Asafu-Adjei ADenise, Chughtai B, Stahl P, Sedrakyan A, Kashanian JA. 2019. A Contemporary Analysis of Dual Inflatable Penile Prosthesis and Artificial Urinary Sphincter Outcomes.. J Urol. 201(1):141-146.

Ahmad FS, Ricket IM, Hammill BG, Eskenazi L, Robertson HR, Curtis LH, Dobi CD, Girotra S, Haynes K, Kizer JR et al.. 2020. Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLE.. Circ Cardiovasc Qual Outcomes. 13(6):e006292.

Mehta B, Goodman S, Ho K, Parks M, Ibrahim SA. 2020. Community Deprivation Index and Discharge Destination after Elective Hip Replacement.. Arthritis Care Res (Hoboken).

Creber RMMasterso, Gaudino MFL. 2019. Commentary: "Get moving early!" Inpatient cardiac rehabilitation reduces unplanned hospitalizations.. J Thorac Cardiovasc Surg.

Jaeckle KA, Ballman KV, van den Bent M, Giannini C, Galanis E, Brown PD, Jenkins RB, J Cairncross G, Wick W, Weller M et al.. 2020. CODEL: Phase III study of RT, RT + Temozolomide (TMZ), or TMZ for newly-diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the initial study design.. Neuro Oncol.

Jaeckle KA, Ballman KV, van den Bent M, Giannini C, Galanis E, Brown PD, Jenkins RB, J Cairncross G, Wick W, Weller M et al.. 2020. CODEL: Phase III study of RT, RT + Temozolomide (TMZ), or TMZ for newly-diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the initial study design.. Neuro Oncol.

Jaeckle KA, Ballman KV, van den Bent M, Giannini C, Galanis E, Brown PD, Jenkins RB, J Cairncross G, Wick W, Weller M et al.. 2020. CODEL: Phase III study of RT, RT + Temozolomide (TMZ), or TMZ for newly-diagnosed 1p/19q Codeleted Oligodendroglioma. Analysis from the initial study design.. Neuro Oncol.

Gordhandas S, Kahn RM, Gamble C, Talukdar N, Maddy B, Nelson BBaltich, Askin G, Christos PJ, Holcomb K, Caputo TA et al.. 2020. Clinicopathologic features of endometrial cancer with mismatch repair deficiency.. Ecancermedicalscience. 14:1061.

Gordhandas S, Kahn RM, Gamble C, Talukdar N, Maddy B, Nelson BBaltich, Askin G, Christos PJ, Holcomb K, Caputo TA et al.. 2020. Clinicopathologic features of endometrial cancer with mismatch repair deficiency.. Ecancermedicalscience. 14:1061.

Edwards DJ, Cortes M, Rykman-Peltz A, Chang J, Elder J, Thickbroom G, Mariman JJ, Gerber LM, Oromendia C, Krebs HI et al.. 2019. Clinical improvement with intensive robot-assisted arm training in chronic stroke is unchanged by supplementary tDCS.. Restor Neurol Neurosci. 37(2):167-180.

Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR, Nahid M, Ringel JB et al.. 2020. Clinical Characteristics of Covid-19 in New York City.. N Engl J Med.

Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, Satlin MJ, Campion TR, Nahid M, Ringel JB et al.. 2020. Clinical Characteristics of Covid-19 in New York City.. N Engl J Med.

Columbo JA, Sedrakyan A, Mao J, Hoel AW, Trooboff SW, Kang R, Brown JR, Goodney PP. 2019. Claims-based surveillance for reintervention after endovascular aneurysm repair among non-Medicare patients.. J Vasc Surg.

He X-Y, Gao Y, Ng D, Michalopoulou E, George S, Adrover JM, Sun L, Albrengues J, Daßler-Plenker J, Han X et al.. 2024. Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment.. Cancer Cell. 42(3):474-486.e12.

He X-Y, Gao Y, Ng D, Michalopoulou E, George S, Adrover JM, Sun L, Albrengues J, Daßler-Plenker J, Han X et al.. 2024. Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment.. Cancer Cell. 42(3):474-486.e12.

Prigerson HG, Bao Y, Shah MA, M Paulk E, LeBlanc TW, Schneider BJ, Garrido MM, M Reid C, Berlin DA, Adelson KB et al.. 2015. Chemotherapy Use, Performance Status, and Quality of Life at the End of Life.. JAMA Oncol. 1(6):778-84.

Garrido MM, Prigerson HG, Bao Y, Maciejewski PK. 2016. Chemotherapy Use in the Months Before Death and Estimated Costs of Care in the Last Week of Life.. J Pain Symptom Manage. 51(5):875-881.e2.

Bao Y, Maciejewski RC, Garrido MM, Shah MA, Maciejewski PK, Prigerson HG. 2018. Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer.. J Pain Symptom Manage. 55(4):1113-1121.e3.